
Bringing Multi-Cancer Tests Closer to Reality
A new method for early detection of 14 cancer types based on glycosaminoglycan profiles shows promise.
A new method for early detection of 14 cancer types based on glycosaminoglycan profiles shows promise.
A new method of early, multi-cancer detection could prove more effective for non-invasive screening than other emerging options.
More companies have begun offering neurofilament light chain blood tests as a cost-effective alternative to conventional methods.
A new test targeting changes in serum proteins can detect breast cancer up to two years before the condition would normally be diagnosed.
Recent study shows the new test can identify a widespread and dangerous class of synthetic cannabinoids called BZO-CHMOXIZID.